Enlimomab
Modify Date: 2025-08-28 11:34:38
Enlimomab structure
|
Common Name | Enlimomab | ||
|---|---|---|---|---|
| CAS Number | 142864-19-5 | Molecular Weight | N/A | |
| Density | N/A | Boiling Point | N/A | |
| Molecular Formula | N/A | Melting Point | N/A | |
| MSDS | N/A | Flash Point | N/A | |
Use of EnlimomabEnlimomab (BI-RR 0001), a murine IgG2a monoclonal antibody to the human ICAM-1, inhibits leukocyte adhesion to the vascular endothelium, thereby decreasing leukocyte extravasation and inflammatory tissue injury. Enlimomab has anti-inflammatory effects, and can be used for stroke research[1] [2] . |
| Name | Enlimomab |
|---|
| Description | Enlimomab (BI-RR 0001), a murine IgG2a monoclonal antibody to the human ICAM-1, inhibits leukocyte adhesion to the vascular endothelium, thereby decreasing leukocyte extravasation and inflammatory tissue injury. Enlimomab has anti-inflammatory effects, and can be used for stroke research[1] [2] . |
|---|---|
| Related Catalog | |
| In Vitro | 在全血中，Enlimomab 以补体依赖的方式激活静息中性粒细胞[1]。 |
| References |
| No Any Chemical & Physical Properties |